Trends in CD4 count at presentation to care and treatment initiation in Sub-Saharan Africa, 2002-2013: A meta-analysis

Clinical Infectious Diseases

Volumn 60, Issue 7, 2015, Pages 1120-1127

  Siedner, Mark J ^a   Ng, Courtney K ^a   Bassett, Ingrid V ^a   Katz, Ingrid T ^a,b   Bangsberg, David R ^a,c   Tsai, Alexander C ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

Author keywords

antiretroviral therapy; HIV AIDS; linkage to care; meta analysis; sub Saharan Africa

Indexed keywords

ANTIVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AFRICA SOUTH OF THE SAHARA; ARTICLE; CD4 LYMPHOCYTE COUNT; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDLINE; META ANALYSIS; OPPORTUNISTIC INFECTION; PATIENT CARE; POPULATION; PRIORITY JOURNAL; VERTICAL TRANSMISSION; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADULT; AGED; FEMALE; HIV INFECTIONS; IMMUNOLOGY; MALE; MIDDLE AGED; STATISTICAL MODEL; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; AGED; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; YOUNG ADULT;

EID: 84926654732     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu1137     Document Type: Article

References (40)

1. United Nations Joint Programme on HIV/AIDS. UNAIDS report on the global AIDS epidemic, 2013. Available at: http://www.unaids. org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS-Global-Report-2013-en.pdf. Accessed 17 March 2014.
2. Bor J, Herbst AJ, Newell ML, Barnighausen T. Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment. Science 2013; 339:961-5.
3. Bendavid E, Holmes CB, Bhattacharya J, Miller G. HIV development assistance and adult mortality in Africa. JAMA 2012; 307:2060-7.
4. Cohen MS, Chen YQ, McCauleyM, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
5. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013; 339:966-71.
6. Siedner MJ, Musinguzi N, Tsai AC, et al. Treatment as long-Term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda. AIDS 2014; 28:267-71.
7. Mills EJ, Bakanda C, Birungi J, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Ann Intern Med 2011; 155:209-16.
8. Fauci AS, Folkers GK. Toward an AIDS-free generation. JAMA 2012; 308:343-4.
9. McNairy ML, El-Sadr WM. Antiretroviral therapy for the prevention of HIV transmission: what will it take?. Clin Infect Dis 2014; 58:1003-11.
10. Odhiambo JO, Kellogg TA, Kim AA, et al. Antiretroviral treatment scale-up among persons living with HIV in Kenya: results from a nationally representative survey. J Acquir Immune Defic Syndr 2014; 66 (suppl 1):S116-22.
11. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treatment and preventing HIV infection. Recommendations for a public health approach. Geneva, Switzerland: WHO, 2013.
12. Castro A, Farmer P. Understanding and addressing AIDS-related stigma: from anthropological theory to clinical practice in Haiti. Am J Public Health 2005; 95:53-9.
13. Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS 2012; 26:2059-67.
14. Lankowski AJ, Siedner MJ, Bangsberg DR, Tsai AC. Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review. AIDS Behav 2014; 18: 1199-223.
15. Katz IT, Ryu AE, Onuegbu AG, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc 2013; 16(3 suppl 2):18640.
16. Stroup DF, Berlin JA, Morton SC, et al. Meta-Analysis of observational studies in epidemiology: a proposal for reporting. Meta-Analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283:2008-12.
17. Lesko CR, Cole SR, Zinski A, Poole C, Mugavero MJ. A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992-2011. Clin Infect Dis 2013; 57: 1027-37.
18. Abaasa AM, Todd J, Ekoru K, et al. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv Res 2008; 8:241.
19. World Health Organization. Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. Geneva, Switzerland: WHO, 2009. Available at: http://www.who.int/hiv/pub/arv/rapid-Advice-Art. pdf. Accessed 21 April 2014.
20. Lahuerta M, Wu Y, Hoffman S, et al. Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006-2011: findings from four sub-Saharan African countries. Clin Infect Dis 2014; 58:432-41.
21. IeDEA and ART Cohort Collaborations; Avila D, Althoff KN, Mugglin C, et al. Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr 2014; 65:e8-16.
22. Hoffman S, Wu Y, Laheurta M, et al. Advanced disease at enrollment in HIV care in four sub-Saharan African countries: change from 2006 to 2011 and multilevel predictors in 2011. AIDS 2014; 28:2429-38.
23. Maman D, Pujades-Rodriguez M, Nicholas S, et al. Response to antiretroviral therapy: improved survival associated with CD4 above 500 cells/μl. AIDS 2012; 26:1393-8.
24. De Cock KM, El-Sadr WM. When to start ART in Africa-An urgent research priority. N Engl J Med 2013; 368:886-9.
25. Gallant JE, Mehta SH, Sugarman J. Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resourcelimited settings?. Clin Infect Dis 2013; 57:884-7.
26. World Health Organization, United Nations Children's Fund, United Nations Joint Programme on HIV/AIDS. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010. Geneva, Switzerland: WHO, 2010.
27. Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011; 8:e1001056.
28. McNairy ML, El-Sadr WM. The HIV care continuum: no partial credit given. AIDS 2012; 26:1735-8.
29. Katz IT, Essien T, Marinda ET, et al. Antiretroviral therapy refusal among newly diagnosed HIV-infected adults. AIDS 2011; 25:2177-81.
30. Musheke M, Ntalasha H, Gari S, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in sub-Saharan Africa. BMC Public Health 2013; 13:220.
31. Sweat M, Morin S, Celentano D, et al. Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study. Lancet Infect Dis 2011; 11:525-32.
32. US Department of State. http://www.state.gov/r/pa/prs/ps/2011/09/172389.htm. Accessed 20 April 2014.
33. National Institutes of Health. http://www.nih.gov/news/health/sep2013/niaid-30.htm. Accessed 20 April 2014.
34. Pasquet A, Messou E, Gabillard D, et al. Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Cote d'Ivoire. PLoS One 2010; 5: e13414.
35. Siedner MJ, Lankowski A, Haberer JE, et al. Rethinking the 'pre' in pretherapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One 2012; 7:e39894.
36. Bedelu M, Ford N, Hilderbrand K, Reuter H. Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis 2007; 196(suppl 3):S464-8.
37. Jani IV, Sitoe NE, Alfai ER, et al. Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet 2011; 378:1572-9.
38. Katz IT, Bassett IV, Wright AA. PEPFAR in transition-implications for HIV care in South Africa. N Engl J Med 2013; 369:1385-7.
39. US President's Emergency Plan for AIDS Relief. Shared responsibility-strengthening results from an AIDS-free generation: latest PEPFAR funding, 2014. Available at: http://www.pepfar.gov/documents/organization/189671.pdf. Accessed 3 May 2014.
40. Hontelez JA, Lurie MN, Barnighausen T, et al. Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med 2013; 10:e1001534.